Cap Insulin Prices - Bring back Insulin Price Reduction Act

Cap Insulin Prices - Bring back Insulin Price Reduction Act

0 have signed. Let’s get to 1,000!
At 1,000 signatures, this petition is more likely to be featured in recommendations!
Hollie Brown started this petition to President Joe Biden and

Diabetes is a very harsh disease, it affects more than 30 million people in the United States. Costing $535 billion in 2018, an increase of 50 percent since 2010. A single vial of insulin costs $300, and because of this, 1 in 4 Americans have admitted to rationing their insulin. Oftentimes leading to cases of diabetic ketoacidosis, and sometimes leading to death. That was the case for one mother, whose daughter was rationing insulin due to the high cost and died at the age of 22 as a result.

So what is diabetes? For now, we will focus on type 1 diabetes, as T1D needs insulin more than the pills for treatment. Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition in which the pancreas produces little or no insulin. Insulin is a hormone needed to allow sugar (glucose) to enter cells to produce energy.

Different factors, including genetics and some viruses, may contribute to type 1 diabetes. Although type 1 diabetes usually appears during childhood or adolescence, it can develop in adults. Despite active research, type 1 diabetes has no cure. Treatment focuses on managing blood sugar levels with insulin, diet, and lifestyle to prevent complications.

Access to insulin for patients with Type 1 diabetes is a matter of life or death. While insulin has existed since the 1920s, the price since then has skyrocketed, especially in recent years. Prices for insulin increased by 197 percent between 2002 and 2013, from $4.34 per milliliter to $12.92 per milliliter. There are three insulin manufacturers serving the United States: Eli Lilly and Co., Novo Nordisk A/S, and Sanofi SA.

Ahead of its hearing on drug pricing in February 2019, the U.S. Senate Committee on Finance sent a letter to Eli Lilly asking why insulin is priced so astonishingly high. A vial of NovoLog, one type of insulin, costs anywhere from $14 to $300 in the United States but only $48 in Singapore, $14 in India, $6 in Austria, and $0 in Italy. 

Although the Trump administration kept promising to lower drug prices, drug costs continue to climb as Americans suffer and pharmaceutical companies profit and their CEOs line their pockets. The government-funded research and major tax benefits that these pharmaceutical companies enjoy help them stay profitable. Meanwhile, they continue to hike up the costs of drugs, particularly life-sustaining drugs such as insulin.

So what can you do to help? Sign this petition! Send a letter to President Biden. To Norris Cochran, the head of the United States Department of Health and Human Services. To attorney general Xavier Becerra, who Joe Biden has nominated to become the 25th United States secretary of health and human services. And lastly, one to your state secretary. 

0 have signed. Let’s get to 1,000!
At 1,000 signatures, this petition is more likely to be featured in recommendations!